Anti-inflammatory and immuno-modulatory studies on LC-MS characterised methanol extract of Gentiana kurroo Royle by Khan Mubashir et al.
RESEARCH ARTICLE Open Access
Anti-inflammatory and immuno-modulatory
studies on LC-MS characterised methanol
extract of Gentiana kurroo Royle
Khan Mubashir1*, Bashir A. Ganai2, Khalid Ghazanfar3, Seema Akbar3, Bilal Rah4, Mudasir Tantry2
and Akbar Masood5
Abstract
Background: In ayurvedic traditional medicine Gentiana kurroo Royle (family; Gentianaceae) is used to treat several
metabolic diseases. This plant is rich in various compounds belonging to flavonoids and glycosides. Till now little work
has been carried out on immunomodulatory and anti-inflammatory potential of this plant. This study confirms the
presence of bioactive compounds and evaluates the anti-inflammatory and immunomodulatory effect of this plant.
Methods: To carry out this work, the methanol extract was investigated in different doses using in vivo and in vitro
models. In vivo study involved haemagglutination titre and DTH methods, and in vitro study was done using
splenocyte proliferation assay and LPS stimulated macrophage culture. TNF-α, IL-6 and NO were assayed using ELISA kit
methods, while NF-κB was evaluated by western blotting. LC-ESI-MS/MS was used for the characterization of the
methanol extract.
Results: The results showed suppression of both humoral and cell mediated immunity in vivo. This effect was also
observed by inhibition of B and T cell proliferation in splenocyte proliferation assay. TNF-α, IL-6 and NO concentrations
were also less in extract treated macrophage cultures. The NF-κB expression was also lowered in treated macrophages
as compared to untreated macrophages. All these observations were found to be dose dependent. LC-MS
characterization of this extract showed the presence of known compounds which are glycosides, alkaloids and
flavonoids in nature.
Conclusion: The methanol extract of this plant was found to be rich in glycoside, alkaloid and flavonoid compounds.
These compounds are probably responsible for the suppression of immune response and anti-inflammatory activity.
The extract as such and identified bioactive compounds can be useful for the treatment of inflammatory disorders.
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Background
Inflammation is an essential protective process preserving
the integrity of organisms against physical, chemical, and
infective insults. Inflammatory diseases majorly develop
by altering the response of T-cells and causing irregularity
in immune system function starting with the migration of
leukocytes, primarily neutrophils [1]. Further, during
inflammation the pro-inflammatory molecules like Nitric
oxide (NO) and TNF-α are produced by macrophages and
the inhibition of NO synthase and TNF-α reverses
inflammatory symptoms [2]. This inflammatory response
is transduced by a variety of signalling pathways. Nuclear
factor kappa B (NF-κB) is one of the essential signalling
molecules acting as a transcription factor for the expres-
sion of iNOS, TNF-α and IL-6 genes by binding to their
promoter regions [3, 4]. Many synthetic drugs like
glucocorticoids are used for the treatment of inflamma-
tory disorders by immune system modulation, but none of
them is without serious adverse effects and are thus highly
unsafe for use in humans. The different synthetic drugs
used against inflammation are reported to produce drug
related toxicities, adverse reactions and iatrogenic effects
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complicating the treatment process [5, 6]. Hence, anti-
inflammatory treatment has observed a shift from syn-
thetic to herbal products. These herbal products with
fewer side effects are mainly the primary and secondary
metabolites [7]. Such herbal drugs with the capacity to in-
hibit cellular and humoral immune responses can have
useful applications in some immune-mediated disorders
including autoimmune diseases [8].
In this perspective the current study was carried out
on Gentiana kurroo Royle used as an effective drug in
ayurveda for the treatment of several metabolic diseases
[9]. Further the flower tops of this plant has been shown
to possess the anti-inflammatory potential [10]. In our
earlier studies different extracts of this plant were
screened for anti-inflammatory and immuno-modulatory
potential and methanol extract was found to show the
maximum potential [11]. So in the current study this ex-
tract was extensively assesssed for its effect on immune
response to explore its protective mechanism against
inflammation.
Methods
Collection, identification and selection of herbal
substance
Gentiana kurroo Royle locally known as Nilkanth
(English name- Indian Gentian) was procured from
sub-alpine region in Dachigam and identified in the
Centre of Plant Taxonomy (COPT), Dept. of Botany,
University of Kashmir. The specimen is retained in
the herbarium of COPT vide voucher no.1804-KASH.
Whole plant material was selected for the study.
Preparation of extracts
The plant material was cleaned, cut into small pieces
and dried under a shade. It was then pulverized into
coarse powder in an electric blender, weighed (~180 g
dry weight) and extracted successively using petroleum
ether, ethyl acetate, methanol and water respectively by
soxhlet extraction each for a period of 96 h. The solvents
were allowed to evaporate in a rotary evaporator at 40–
45 °C and the extracts obtained were stored in a refriger-
ator at 4 °C. The yields of the petroleum ether, ethyl
acetate, methanol and aqueous extracts were 5.6, 4.3,
5.3, and 4.2% (w/w), respectively.
Animals
Male Balb/C mice 8–10 weeks old and weighing 18–
22 g, were used for the immuno-modulatory study. The
animals were housed under standard laboratory condi-
tions with a temperature of (25 ± 2)°C, relative humidity
of (55 ± 10)%, 12/12 h light–dark cycles and fed with
standard pellet diet (Lipton India Ltd.) and water was
given ad libitum.
Experimental protocols
All experimental protocols and the number of animals
used for the experimental work were duly approved by
the Institutional Animals Ethics Committee (IAEC); of
Indian Institute of Integrative Medicine (CSIR), Canal
Road Jammu (CPCSEA registration No. 67/CPCSEA/99).
The experimental work on animals was carried out as
per the guidelines set by committee for the purpose
of control and supervision of experiments on animals
(CPCSEA).
Preliminary toxicity study
Five male Balb/C mice 8–10 weeks old were taken. Each
animal was tested with the methanol extract at an oral
dosage of 2000 mg/kg bw as per OECD guidelines. The
mice were observed for 24 h for any signs of toxicity in-
cluding change in behaviour or death.
Humoral antibody response
The mice were divided into 6 groups, each group consist-
ing of 5 animals. Mice in group I (control) were given 1%
tween 20, 0.2 mL/mice for 14 days. Mice in group II-V
were given the extract at a dose range of 25, 50, 100,
200 mg/kg bw respectively for 14 days. Mice in group VI
were given cyclophosphamide (50 mg/kg) on day 1 and
continued for 14 days. All drugs were given orally.
The animals were immunised by injecting 200 μL of
5 × 109 SRBC’s/mL intraperitonially (i.p) on day 1. Blood
samples were collected in microliter tubes from individual
animals in all the groups by retro-orbital vein puncture on
day 7 and day 14. The blood samples were centrifuged
and the serum was separated. Then haemoglutination pri-
mary and secondary titres were performed [12, 13].
Delayed type hypersensitivity
This method was carried out to determine the effect of
extracts on the cell-mediated immunity. Animals were
divided into six groups of 5 each. Group I served as sen-
sitized control, as in humoral antibody titre. Mice in
group II-V were administered methanol extract at a dose
range of 25, 50, 100, 200 mg/kg bw respectively after
SRBC’s sensitization (i.p), once daily for 14 days. Cyclo-
phosphamide (50 mg/kg bw) was administered as stand-
ard T-cell suppressor (group VI). The mice were
challenged on day 14 by injecting 0.02 mL of SRBC’s
antigen subcutaneous into the right hind footpad,
whereas left hind footpad served as control [14, 15]. The
footpad thickness was measured with micrometre calli-
per (pitch 0.01 mm) after 24 and 48 h of SRBC’s
challenge.
Ex-vivo TNF-α assay
The male Balb/C mice dosed for 14 days with variable
concentrations (25–200 mg/kg) of methanol extract
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were analysed for serum TNF-α. Blood (0.5 mL) was
taken on the 14th day by retro-orbital puncture from the
mice used for the study of DTH reaction. Blood was
kept on standing for 2 h at room temperature (24 °C).
After clotting of blood, the tubes were centrifuged at
8000 rpm for 10 min, at 4 °C. The serum so collected
was evaluated for the measurement of TNF-α using
mouse TNF-α ELISA kit (R&D systems, USA), as per
the instructions of the manufacturer.
Collection of peritoneal macrophages and nitrite assay
Male Balb/C mice were i.p. injected 4% sodium thiogly-
collate media 1 mL per mice. Under aseptic conditions
mice were euthanized after 24 h and injected 10 mL of
RPMI 1640 medium in peritoneal cavity. After 5 min,
the medium was taken out and centrifuged at 1800× g
for 10 min at 4 °C. The cell pellet was resuspended in
RPMI 1640 medium. The macrophages (3× 106) were
cultured in 96 well micro-plate in the presence of LPS
(1 μg/mL), β-Methasone (0.001 μg/mL) and variable
doses of methanol extract (25–200 μg/mL). The plates
were incubated at 37 °C in a humid saturated atmos-
phere containing 5% CO2 for 24 h. Supernatants were
collected after centrifugation and stored at −80 °C for
determination of cytokines. The supernatants were used
for nitrite assay using Griess reagent. For the NO2 assay
(nitrite content), 100 μl of the culture media was
incubated with 100 μL Griess reagent (0.1% naphthyl-
ethylenediamide and 1% sulphanilamide in 2.5% phos-
phoric acid solution) at room temperature for 10 min in
96 well micro-plate [16]. Optical density was measured
at 540 nm using ELISA plate reader. The nitrite
concentration was determined by extrapolation from a
sodium nitrite (NaNO2) standard curve and the results
expressed in μM.
IL-6 and TNF-α measurements
The harvested supernatants from cultured peritoneal
macrophages were used for the measurement of pro-
inflammatory cytokines (IL-6 and TNF-α) using mouse
IL-6 and TNF-α ELISA kits (R&D systems, USA), as per
the instructions of the manufacturer.
Lymphocyte proliferation studies on mice splenocytes
Spleen collected under aseptic conditions in IRPMI, was
minced using a pair of scissors and passed though a fine
steel mesh to obtain a homogenous cell suspension and
the erythrocytes were lysed with ammonium chloride
(0.8% w/v). After centrifugation (380 × g at 4 °C for
10 min), the pelleted cells were washed three times with
PBS and resuspended in complete medium [RPMI 1640
supplemented with 12 mM HEPES (pH 7.1), 0.05 mM
2-mercaptoethanol, 100 IU/mL penicillin, 100 μg/mL
streptomycin and 10% FBS]. The cell number was counted
with a haemocytometer by the trypan blue dye exclusion
technique. Cell viability exceeded 95% [17].
To evaluate the effect of methanol extract on the pro-
liferation of splenic lymphocytes, the spleen cell suspen-
sion (2 × 106 cells/mL) was pipetted into 96 well plates
(200 μl/well) and cultured at 37 °C for 72 h in a humid
saturated atmosphere containing 5% CO2 in the pres-
ence of Con-A (5 μg/mL), LPS (1 μg/mL) and variable
doses of methanol extract (25–200 μg/mL). β-methasone
(BMS) was used as standard drug at a concentration of
0.001 μg/mL. After 72 h, 20 μL of MTT (5 mg/mL) was
added to each well and plates were incubated for 4 h.
The plates were centrifuged (1400 × g, 5 min) and the
untransformed MTT was removed carefully by pippet-
ing. To each well, 100 μl of DMSO working solution
(192 μl DMSO with 8 μl 1 M HCl) was added and the
absorbance was evaluated in ELISA reader at 570 nm
after 15 min. Reduction of MTT indicated the spleno-
cyte proliferation.
Western blot analysis
Peritoneal macrophages collected from male Balb/C
(0.5 × 106 cells) were incubated overnight and exposed
to different concentrations of methanol extract (25–
100 μg/mL) with DMSO as vehicle and β-methasone
(0.001 μg/mL) as positive control. LPS (1 μg/mL) was
also added to all wells except the vehicle, thus having
two vehicles - DMSO as vehicle (unstimulated), vehicle
+ LPS (stimulated) so as to have a better understanding
of the results. Cells were accordingly rinsed with PBS,
trypsinized and collected after 24 h incubation and were
lysed with lysis buffer (HEPES 1 mM/L, KCl 60 mM/L,
NP-40 0.3%, EDTA 1 mM/L, DTT 1 mM/L, Sodium
orthovandate 1 mM/L, PMSF 0.1 mM/L, cocktail prote-
ase inhibitor). The cell extractions were centrifuged at
12,000 rpm for 10 min at 4 °C. Supernatant was col-
lected for protein quantification. Protein concentration
was determined by the standard Bradford method [18].
Equal amount (20 μg) of protein from each sample was
subjected to SDS-PAGE (12%) and proteins were trans-
ferred to membrane (Millipore), blocked with 5% (w/v)
non-fat milk in PBS containing 0.1% Tween-20 and
probed with anti-NF-кB (p65) and anti-β-actin for 3 h at
room temperature overnight at 4 °C and subsequently
washed, probed with species specific secondary anti-
bodies coupled to horseradish peroxidase. Immuno-
reactive proteins were detected by enhanced chemilu-
minescence plus (Amersham).
Liquid chomatography–tandem mass spectrometry
(LC–ESI-MSMS)
LC–MS equipment (LC–MS QqQ-6410B Agilent
Technologies) comprised a chomatographic system
(1260 Infinity Agilent Technologies) coupled with an
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Agilent Triple Quad mass spectrometer fitted with an
ESI source. MS conditions were the following: MS range
100–1200 Da, MSn spectra were obtained using both
positive and negative modes, nebulizer gas 45 Psi, gas
temperature 325 °C, capillary voltage 4000 V.
HPLC analysis was carried out by an Agilent 1260 in-
finity series. A Chomolith RP-18e column (4.6 mm ID,
50 mm length) (Merck) was used. Mobile phase con-
sisted of (A) aqueous formic acid (0.1%) and (B) metha-
nol. Gradient condition was; 0–8 min, linear gradient
from 12 to 25% of B; 8–12 min, isocratic conditions at
25% of B; 12–16 min, linear gradient from 25 to 40% of
B; 16–40 min, linear gradient from 40 to 50% of B,
40–50 min, linear gradient from 50 to 100% of B.
Flow rate: 1 mL/min.
Statistical analysis
Data is expressed as Mean ± SD and statistical analysis
was carried out employing the one-way ANOVA followed
by Post Hoc Tukey’s HSD test and Bonferroni multiple
comparison test using SPSS 16 software. p values < 0.05
are being taken as statistically significant.
Results
Preliminary toxicity study
The methanol extract was found to be non-toxic at a
dose of 2000 mg/kg bw.
Haemagglutination antibody titre
In the current study as is evident from Table 1, the
methanol extract showed increased activity with the in-
crease in dose. The effect was found to be more in pri-
mary titre than in the secondary titre. At a dose of
200 mg/kg the methanol extract had maximum effect on
HA titre and also more than cyclophosphamide. The in-
hibition at this dose by methanol extract in primary and
secondary humoral response observed was 66.21 and
55.26% respectively (Fig. 1). Cyclophosphamide treated
group showed 39.39 and 52.63% inhibitory response in
the primary & secondary titres. Statistical analysis
showed significance at p < 0.05, of the results obtained
between the control and the treated groups.
Delayed type hypersensitivity
DTH was carried out to study the effect of different
doses of methanol extract on non-specific cellular
immune response. Results obtained showed dose
dependent effect in cellular immune response (Table 2).
In control group edema formation was high, but was
found to be less in treated groups. In positive control
group the edema formation was less than control group
but methanol extract treated group at a dose of 200 mg/kg
had least edema formation with an inhibition of 70.33 &
75.66% in cellular response after 24 & 48 h respectively,
while in cyclophosphamide treated group (50 mg/kg bw)
the suppression in cellular immune response was 58.52 &
65.61% as compared to control group (Fig. 2). The results
Table 1 Effect of methanol extract on SRBC specific humoral
immune response in Balb/C mice. (mean ± S.E) (n = 5)
Humoral response
Treatment Dose (mg/kg) Primary titre Secondary titre
Control SRBC 6.6 ± 0.24a 7.6 ± 0.24a
I 25 5.2 ± 0.2ab 6.4 ± 0.24b
II 50 4.4 ± 0.24bc 5.4 ± 0.24b
III 100 3 ± 0.45cd 3.8 ± 0.37c
IV 200 2.6 ± 0.24d 3.4 ± 0.24c
Cyclophosphamide 50 4 ± 0.45bcd 3.6 ± 0.24c
Values along the same column with different superscripts are statistically





















Fig. 1 Graph showing %age inhibition of primary and secondary
humoral response in Balb/C mice by methanol extract (25–200 mg/kg).
Cyclophosphamide (50 mg/kg) was taken as standard drug
Table 2 Effect of methanol extract on SRBC specific cellular








Control SRBC 0.728 ± 0.01a 0.378 ± 0.007a
I 25 0.554 ± 0.034b 0.278 ± 0.018b
II 50 0.458 ± 0.034c 0.208 ± 0.011c
III 100 0.276 ± 0.009d 0.118 ± 0.011d
IV 200 0.216 ± 0.01d 0.092 ± 0.002d
Cyclophosphamide 50 0.302 ± 0.01d 0.13 ± 0.01d
Values along the same column with different superscripts are statistically
significant to each other using Tukey’s HSD test (p < 0.05)
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obtained were found to be significant in relation with con-
trol group at p < 0.05.
Ex-vivo TNF-α assay
The results indicated a decrease in serum TNF-α levels
of treated groups as compared to control in a dose
dependent manner. The group administered with
methanol extract at a dose range of 200 mg/kg signifi-
cantly (p < 0.05) decreased serum TNF-α (174.96 pg/mL)
as compared to control (468.09 pg/mL). Cyclophospha-
mide treated group significantly (p < 0.05) decreased the
TNF-α in serum (Fig. 3).
Effect of methanol extract on NO production in
macrophages
Since NO is also known as a pro-inflammatory mediator
in different acute and chronic inflammatory diseases, we
addressed whether methanol extract modulates the NO
production from macrophages stimulated by LPS. The
extract inhibited the NO production in a dose
dependent manner at a dose range of 25–200 μg/mL.
The maximum inhibition was observed at 200 μg/mL
dose compared to control. Increase in the dose of
methanol extract indicated a significant inhibition in the
production of nitrite content (Fig. 4). BMS also showed
a significant inhibition (p < 0.05) in nitrite content com-
pared to control.
Effect of methanol extract on the TNF-α and IL-6 release
in mice peritoneal macrophages stimulated with LPS
Results indicated that the extract inhibited the release of
these two cytokines from macrophages in a dose
dependent manner. At a dose of 200 μg/mL, inhibition
in TNF-α (Fig. 5a) and IL-6 (Fig. 5b) was found to be
most significant (p < 0.05). BMS also registered a sig-
nificant inhibition (p < 0.05) in the release of TNF-α and
IL-6 from LPS stimulated macrophages compared to
control.
Effect of methanol extract on splenocyte proliferation
assay
The results observed were found to show suppression of
both T and B-cell proliferation of splenocytes at doses
(25–200 μg/mL) in a dose dependent manner compared
to control. Maximum observation was registered at a
dose of 200 μg/mL (Fig. 6). The extract indicated more
inhibition of T-cell than the B-cell; however the differ-






















Fig. 2 Graph showing 24 and 48 h %age inhibition of cell mediated
response in Balb/C mice by methanol extract (25–200 mg/kg).


























Fig. 3 Effect of methanol extract on serum TNF-α concentration in
male Balb/C mice. The results in graph include control group,
methanol extract treated groups (25–200 mg/kg) and positive
control group treated with cyclophosphamide (50 mg/kg). Values
are mean ± SD (n = 5); *p < 0.05 (control vs. treated groups); one-way



















Fig. 4 Effect of methanol extract on the nitrite content in mice
peritoneal macrophages. Values are means ± SD; *p< 0.05 (control vs.
treated groups); one-way ANOVA followed by Bonferroni multiple
comparison test. All tests were carried out in triplets and repeated twice
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showed significant inhibition (p < 0.05) of both T and
B-cell proliferation compared to control.
Effect of methanol extract on NF-kappa B expression in
mice peritoneal macrophages stimulated with LPS
In presence of LPS (stimulated) increased concentra-
tions of NF- кB (p65) were registered in protein ex-
tracts of peritoneal macrophages after 24 h as
compared to vehicle (unstimulated). The results indi-
cated reduced expression of NF-kappa B (p65) in
presence of the methanol extract. The methanol ex-
tract was used in a dose range of 25–100 μg/mL and
showed dose-dependent inhibition in the expression
of NF-kappa B (p65). At a dose of 100 μg/mL max-
imum inhibition was observed up to 0.23 fold
decrease in its expression (Fig. 7). BMS used as
standard drug showed significant decrease in the ex-
pression of NF-kappa B (p65).
LC–ESI-MS/MS analysis
The methanol extract was analyzed for the presence of
different compounds by liquid chomatography tandem
mass spectrometry (LC-ESI-MS/MS). The total ion MS
chomatogram (TIC) as shown in Fig. 8 showed a
number of peaks corresponding to different chemical
constituents present in the extract. The major peaks
were further analysed under both positive and negative
ESI-MS modes. Further the molecular ion peaks along
with the MS fragmentation pattern obtained were com-
pared with the molecular ion peaks of different com-
pounds reported in the literature for the identification of
the compounds [19–22]. The compounds identified are
given in the Table 3 showing their actual mass (m/z), mass












































Fig. 5 a Effect of methanol extract on TNF-α release in mice peritoneal
macrophages. Values are mean ± SD., *p < 0.05 (control vs. treated
groups); one-way ANOVA followed by Bonferroni multiple comparison
test. All tests were carried out in triplets and repeated twice. b Effect of
methanol extract on IL-6 release in mice peritoneal macrophages.
Values are mean ± SD., *p < 0.05 (control vs. treated groups); one-way
ANOVA followed by Bonferroni multiple comparison test. All tests were




























Fig. 6 Effect of methanol extract on ConA and LPS-stimulated splenocyte
cell proliferation. Values are mean± SD showing OD at 570 nm, *p< 0.05
(control vs. treated groups); one-way ANOVA followed by Bonferroni
multiple comparison test. All tests were carried out in triplets and
repeated twice
Fig. 7 NF- КB (p65) expression in mice peritoneal macrophages.
Extract treated cultures were found to show decreased expression of
NF-kappa B (p65) as compared to stimulated and unstimulated
vehicle. β-actin was used as loading control
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area sum%. The compounds in the ESI+ mode [M+Na]+
at m/z 399.00, 397.00, 379.00, 279.00 coincides with
loganic acid (m/z = 376.13), swertiamarin (m/z = 374.12),
gentiopicroside (m/z = 356.11), gentisin (m/z = 256.07) re-
spectively. In ESI+ [M +K]+ mass spectra mode at m/z
214.90 single compound gentianine (m/z = 175.06) was
identified. The compounds sweroside (m/z = 358.12) and
norswertianolin (m/z = 422.07) were identified in the
ESI+ [M + H]+ mass spectra mode at m/z 359.10 and
423.00, while in ESI− [M – H]− mass spectra mode at
m/z 1007.10, 444.90, 551.20 and 255.10 match with the
measured masses of 4′′-O-β-D-glucosyl-6′-O-(4-O-β-D-
glucosyl caffeoyl) linearoside (m/z = 1008.31), swertisin
(m/z = 446.12), gentioside (m/z = 552.14) and isogentisin
(m/z = 256.07) (Fig. 9).
Discussion
Inflammation is a protective process that is essential for
the preservation of the integrity of the organism in the
event of physical, chemical and infectious damage.
Often, it is found that inflammatory response to severe
lesions erroneously damages normal tissue [23]. It is well
established that activated immunocytes are involved in
inflammation process, particularly macrophages, which
play a crucial role in specific and nonspecific immune
responses during inflammation [24]. So the methanol
fraction was used to demonstrate the effect on the im-
mune system using HA titre and DTH method for deter-
mining its effect on humoral and cell mediated immune
responses respectively. The methanol fraction was ob-
served to have an immunosuppressive effect by inhibit-
ing the antibody formation and the cellular immune
response in a dose dependent manner. One of the major
pro-inflammatory cytokine is TNF-α which is produced
by different immune cells and its rate of production and
hence its concentration in blood demonstrates the ex-
tent of inflammatory response [25]. Blood samples were
taken from the treated and untreated groups of animals
used in the HA titre and DTH models. The results indi-
cated marked difference in the concentration of serum
TNF-α between the treated and untreated groups. Fur-
ther the serum TNF-α concentration in serum of treated
Fig. 8 Total Ion Chomatogram (TIC) of the methanol extract
Table 3 Identified compounds in the methanol extract by LC-ESI-MS/MS
S.No. Compound Actual mass (m/z) ESI+ (m/z) ESI− (m/z) RT (min) Area sum%
1. 4″-O-β-D-glucosyl-6′-O-(4-O-β-D-glucosylcaffeoyl)-linearoside 1008.31 1007.10 [M - H]− 1.48 20.42
2. Loganic acid 376.13 399.00 [M + Na]+ 6.84 3.58
3. Swertiamarin 374.12 397.00 [M + Na]+ 7.3 4.25
4. Gentiopicroside 356.11 379.00 [M + Na]+ 7.95 32.66
5. Swertisin 446.12 444.90 [M - H]− 7.95 32.66
6. Sweroside 358.12 359.10 [M + H]+ 8.48 3.58
7. Norswertianolin 422.07 423.00 [M + H]+ 12.13 2.41
8. Gentisin 256.07 279.00 [M + Na]+ 23.81 6.43
9. Gentioside 552.14 551.20 [M - H]− 28.22 0.13
10. Isogentisin 256.07 255.10 [M - H]− 29.88 1.52
11. Gentianine 175.06 214.90 [M + K]+ 33.44 17.85
RT Retention time
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animals showed decrease with increase in dose of the
methanol extract and hence the dose dependent effect.
During the progression of inflammation, the most
known important mediators produced by macrophages
include NO, prostanoids, TNF-α, and Interleukins [26, 27].
Among these inflammatory cytokines, TNF-α , IL-1β , and
IL-6 are considered the most crucial mediators for the in-
flammatory process, mediating immunity and activating
macrophages [28, 29]. Lipopolysaccharide (LPS)-stimulated
macrophages using Raw264.7 cells is a well-established
in vitro inflammation model [29, 30]. This model was used
for investigating suppressive effect of methanol extract on
the release of inflammatory mediators-NO, TNF-α
and IL-6 by LPS activated macrophages. The extract
inhibited the production of these mediators in a dose
dependent manner from LPS stimulated macrophages.
These results infer that the contribution of methanol ex-
tract in anti-inflammatory activity might be by inhibition
Fig. 9 Structures of the various identified compounds in the methanol extract. 1 4″-O-β-D-glucosyl-6′-O-(4-O-β-D-glucosylcaffeoyl)-linearoside.
2 Loganic acid, 3 Swertiamarin, 4 Gentiopicroside, 5 Swertisin, 6 Sweroside, 7 Norswertianolin, 8 Gentisin, 9 Gentioside, 10 Isogentisin,
11 Gentianine
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of the production of these pro-inflammatory mediators
from immune cells. The effect of methanol extract on the
proliferation of B-cells and T-cells in response to LPS and
ConA respectively, was investigated using MTTassay. The
methanol extract was found to significantly inhibit the
proliferation of both cells in a dose dependent manner.
The extract indicated more inhibition of T-cell than the
B-cell; however the difference was not so high. These re-
sults are consistent with above results where the methanol
extract inhibited the humoral and cell mediated immune
response. It is well known that B-cells produce antibodies
in response to the antigens while T-cells help in framing
the cellular response against the antigens. Because NF-κB
acts as transcription factor and thus causes induction of
iNOS, TNF- α , and IL-6 genes by binding to their pro-
moter regions [3, 4, 31–33]. So it was essential to investi-
gate its expression while studying the production of these
cytokines. The expression of NF-кB (p65) in mice periton-
eal macrophages stimulated with LPS was reduced in
presence of different concentrations of the methanol ex-
tract. So the reduced production of the pro-inflammatory
mediators observed above may be attributed to inhibition
in the expression of NF-кB (p65) and hence the effect
against the inflammation.
The plant secondary metabolites - Iridoids and flavo-
noids are reported to have anti-inflammatory potential
[34, 35]. Various compounds belonging to Iridoids and
flavonoids were found to be present in methanol extract.
Among them loganic acid, swertiamarin and gentianine
are reported to possess the anti-inflammatory potential
[36–38]. The anti-inflammatory potential of methanol
extract is probably due to these compounds.
Conclusion
Our research results demonstrate that G. kurroo possess
anti- inflammatory activity. This activity was mediated by
suppression of immune system- where both the immune
cells as well as the cytokines were found to be inhibited.
The plant extract as such and the identified bioactive com-
pounds like the loganic acid, swertiamarin and gentianine
may be used as natural anti-inflammatory compounds.
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